Body composition and metabolic syndrome in patients with type 1 diabetes

被引:5
|
作者
Zeng, Qiong [1 ]
Chen, Xiao-Jing [2 ]
He, Yi-Ting [2 ]
Ma, Ze-Ming [2 ]
Wu, Yi-Xi [3 ]
Lin, Kun [3 ]
机构
[1] Shantou Univ, Affiliated Hosp 1, Dept Neurol, Med Coll, Shantou 515041, Guangdong, Peoples R China
[2] Shantou Univ, Med Coll, Shantou 515041, Guangdong, Peoples R China
[3] Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Endocrinol, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China
关键词
Body composition; Metabolic syndrome; Insulin resistance; Visceral fat; Estimated glucose disposal rate; CARDIOVASCULAR-DISEASE RISK; INSULIN-RESISTANCE; WEIGHT-GAIN; COMPLICATIONS; OBESITY; FAT; AUTOIMMUNITY; ASSOCIATION; ADOLESCENTS; OVERWEIGHT;
D O I
10.4239/wjd.v15.i1.81
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND In recent years, the prevalence of obesity and metabolic syndrome in type 1 diabetes (T1DM) patients has gradually increased. Insulin resistance in T1DM deserves attention. It is necessary to clarify the relationship between body composition, metabolic syndrome and insulin resistance in T1DM to guide clinical treatment and intervention. AIM To assess body composition (BC) in T1DM patients and evaluate the relationship between BC, metabolic syndrome (MS), and insulin resistance in these indi-viduals. METHODS A total of 101 subjects with T1DM, aged 10 years or older, and with a disease duration of over 1 year were included. Bioelectrical impedance analysis using the Tsinghua-Tongfang BC Analyzer BCA-1B was employed to measure various BC parameters. Clinical and laboratory data were collected, and insulin resistance was calculated using the estimated glucose disposal rate (eGDR). RESULTS MS was diagnosed in 16/101 patients (15.84%), overweight in 16/101 patients (15.84%), obesity in 4/101 (3.96%), hypertension in 34/101 (33.66%%) and dyslipidemia in 16/101 patients (15.84%). Visceral fat index (VFI) and trunk fat mass were significantly and negatively correlated with eGDR (both P < 0.001). Female patients exhibited higher body fat percentage and visceral fat ratio compared to male patients. Binary logistic regression analysis revealed that significant factors for MS included eGDR [P = 0.017, odds ratio (OR) = 0.109], VFI (P = 0.030, OR = 3.529), and a family history of diabetes (P = 0.004, OR = 0.228). Significant factors for hypertension included eGDR (P < 0.001, OR = 0.488) and skeletal muscle mass (P = 0.003, OR = 1.111). Significant factors for dyslipidemia included trunk fat mass (P = 0.033, OR = 1.202) and eGDR (P = 0.037, OR = 0.708). CONCLUSION Visceral fat was found to be a superior predictor of MS compared to conventional measures such as body mass index and waist-to-hip ratio in Chinese individuals with T1DM. BC analysis, specifically identifying visceral fat (trunk fat), may play an important role in identifying the increased risk of MS in non-obese patients with T1DM.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus
    Momesso, Denise Prado
    Bussade, Isabela
    Balarini Lima, Giovanna A.
    Coelho Fonseca, Leniane Pereira
    Tavares Russo, Luis Augusto
    Kupfer, Rosane
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2011, 55 (03) : 189 - 193
  • [2] Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome
    Gravholt, Claus H.
    Jensen, Anne S.
    Host, Christian
    Bojesen, Anders
    ACTA PAEDIATRICA, 2011, 100 (06) : 871 - 877
  • [3] Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition
    Bojesen, Anders
    Host, Christian
    Gravholt, Claus H.
    MOLECULAR HUMAN REPRODUCTION, 2010, 16 (06) : 396 - 401
  • [4] BODY COMPOSITION AND THE METABOLIC IMPACT OF WEIGHT EXCESS IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS
    Lichiardopol, R.
    Florentiu, A.
    Radoi, V.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2010, 6 (04) : 493 - 506
  • [5] Association between Metabolic Syndrome Criteria and Body-composition Components in Children with Type 1 Diabetes Mellitus
    Saki, Forough
    Setoodehnia, Zahra
    Javanmardi, Haniyeh
    Omrani, Gholamhossein Ranjbar
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2016, 4 (10): : 3709 - 3717
  • [6] EFFECT OF DAPAGLIFLOZIN ON BODY COMPOSITION IN PATIENTS WITH TYPE 1 DIABETES
    Bosch Sierra, N.
    Salazar Leon, J. D.
    Grau Del Valle, C.
    Marco Exposito, J.
    Zaragoza Villena, B.
    Banuls Morant, C.
    Sola Izquierdo, E.
    Morillas Arino, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A167 - A168
  • [7] Metabolic syndrome among patients with type 1 diabetes mellitus
    Nadas, J.
    Putz, Z.
    Fovenyi, J.
    Gaal, Z.
    Gyimesi, A.
    Hidvegi, T.
    Hosszufalusi, N.
    Neuwirth, G.
    Oroszlan, T.
    Panczel, P.
    Vandorfi, G.
    Winkler, G.
    Wittmann, I.
    Jermendy, G.
    JOURNAL OF HYPERTENSION, 2007, 25 : S76 - S76
  • [8] Overweight and metabolic Syndrome in Patients with Type 1 Diabetes mellitus
    Winhofer, Yvonne
    Wolf, Peter
    Smajis, Sabina
    Wrba, Thomas
    Luger, Anton
    Krebs, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S159 - S159
  • [9] Is there a metabolic syndrome in Type 1 diabetes?
    Schauer, UJW
    DIABETOLOGIA, 2003, 46 : A350 - A350
  • [10] Metabolic syndrome and type 1 diabetes
    Mnif, F.
    Kacem, F. Hadj
    Mnif, M.
    Ben Salah, R.
    Marwene, F.
    Cheikrouhou, A.
    Abid, M.
    DIABETES & METABOLISM, 2012, 38 : A75 - A75